Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 234.08 |
| Open | 233.95 |
| Bid | 231.79 x 800 |
| Ask | 239.09 x 800 |
| Day's range | 231.11 - 234.75 |
| 52-week range | 220.86 - 319.76 |
| Volume | |
| Avg. volume | 979,334 |
| Market cap | 33.999B |
| Beta (5Y monthly) | 0.08 |
| PE ratio (TTM) | 23.30 |
| EPS (TTM) | 10.07 |
| Earnings date | 13 Feb 2024 - 19 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 323.48 |
ZacksAnnovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why
Annovis' (ANVS) shares surge on the successful development of its lead candidate in Alzheimer's disease.
Simply Wall St.Are Biogen Inc.'s (NASDAQ:BIIB) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
With its stock down 13% over the past three months, it is easy to disregard Biogen (NASDAQ:BIIB). It is possible that...
- Simply Wall St.
The past five years for Biogen (NASDAQ:BIIB) investors has not been profitable
For many, the main point of investing is to generate higher returns than the overall market. But every investor is...
© 2023 Yahoo. All rights reserved.